SP1 and leukemia: Liu et al. [26] found that miR-29b levels were significantly elevated in AML leukemia stem cells compared with non-leukemia stem cells and the miR-29b silencing resulted in increased Sp1 in AML cells, it is a promoter in acute myeloid leukemia.